Thrombosis Journal
Volume 6
|
Viewing options:Associated material:Related literature:- Articles citing this article
- Other articles by authors
- Related articles/pages
Tools:Post to:
|
  ReviewPrevention and treatment of venous thromboembolism with low-molecular-weight heparins: Clinical implications of the recent European guidelinesPaolo Prandoni  Department of Cardiothoracic and Vascular Sciences, Thromboembolism Unit, University of Padua, Italy  author email corresponding author email
Thrombosis Journal 2008,
6:13doi:10.1186/1477-9560-6-13
|
|
| Published: |
9 September 2008 |
Abstract
Venous thromboembolism (VTE) is an important cause of avoidable morbidity and mortality. However, routine prophylaxis for at-risk patients is underused. Recent guidelines issued by an international consensus group, including the International Union of Angiology (IUA), recommend use of low-molecular-weight heparins (LMWHs) for the treatment of acute VTE and prevention of recurrence, and for prophylaxis in surgical and medical patients. This review highlights current inadequacies in the provision of thromboprophylaxis, and considers the clinical implications of the European guidelines on the prevention and treatment of VTE. | 
on Google Scholar
